Locus Cell Co., Ltd. (TPEX:6891)
Taiwan · Delayed Price · Currency is TWD 50.00
-2.30 (-4.40%)
Jun 25, 2026, 2:04 PM CST
Locus Cell Market Cap
Locus Cell has a market cap or net worth of 9.94 billion as of June 25, 2026. Its market cap has increased by 130.15% in one year.
Market Cap
9.94B
Enterprise Value
9.49B
Revenue
12.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
50.00
Market Cap Chart
Since April 28, 2022, Locus Cell's market cap has increased from 9.88B to 9.94B, an increase of 0.63%. That is a compound annual growth rate of 0.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 9.94B | 72.87% |
| Dec 31, 2025 | 5.75B | 44.14% |
| Dec 31, 2024 | 3.99B | -36.67% |
| Dec 29, 2023 | 6.30B | -12.86% |
| Dec 30, 2022 | 7.23B | -26.82% |
| Apr 28, 2022 | 9.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medigen Vaccine Biologics | 14.93B |
| Ever Supreme Bio Technology | 14.40B |
| EirGenix | 14.10B |
| Tanvex BioPharma | 11.62B |
| Polaris Group | 11.26B |
| ACRO Biomedical | 9.40B |
| AP Biosciences | 8.56B |
| PharmaEngine | 8.28B |